Literature DB >> 25761858

Serine protease HtrA1 as an inhibitor on proliferation invasion and migration of gastric cancer.

Zhiguo Zhao1, Huifang Li, Chuanyi Wang, Wanfang Xu, Junfeng Sun, Wenzhao Zhao.   

Abstract

HtrA1, as serine protease lower expressed in various human solid tumors, can down-regulate cell growth and proliferation. In this study, we focus on whether overexpressed HtrA1 can inhibit the growth of gastric cancer in vitro. This study found the HtrA1 is lower expressed in gastric cancer tissue than in normal gastric tissue. When HtrA1 is highly expressing with recombinant plasmid in gastric cancer cell lines SGC-7901 and AGS, it weakened cell proliferation, invasion, and migration in vitro. These data suggested that HtrA1 as an inhibitor in gastric cancer cells resulted in anti-proliferation, reduced invasion, decreased migration, and suppressed growth and may be an effective molecular targets on gastric cancer treatment.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25761858     DOI： 10.1007/s12032-015-0524-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  23 in total

1.  Primary structure of a putative serine protease specific for IGF-binding proteins.

Authors:  J Zumbrunn; B Trueb
Journal:  FEBS Lett       Date:  1996-12-02       Impact factor: 4.124

2.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Authors:  Sooryanarayana Varambally; Jianjun Yu; Bharathi Laxman; Daniel R Rhodes; Rohit Mehra; Scott A Tomlins; Rajal B Shah; Uma Chandran; Federico A Monzon; Michael J Becich; John T Wei; Kenneth J Pienta; Debashis Ghosh; Mark A Rubin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

3.  Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.

Authors:  Jeremy Chien; Giovanni Aletti; Alfonso Baldi; Vincenzo Catalano; Pietro Muretto; Gary L Keeney; Kimberly R Kalli; Julie Staub; Michael Ehrmann; William A Cliby; Yean Kit Lee; Keith C Bible; Lynn C Hartmann; Scott H Kaufmann; Viji Shridhar
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

4.  Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.

Authors:  Zhi-Jun Sun; Gang Chen; Wei Zhang; Xiang Hu; Yang Liu; Qian Zhou; Ling-Xing Zhu; Yi-Fang Zhao
Journal:  Mol Pharmacol       Date:  2010-10-19       Impact factor: 4.436

5.  Analysis of HtrA1 serine protease expression in human lung cancer.

Authors:  Vincenzo Esposito; Mara Campioni; Antonio De Luca; Enrico P Spugnini; Feliciano Baldi; Roberto Cassandro; Alessandro Mancini; Bruno Vincenzi; Angela Groeger; Mario Caputi; Alfonso Baldi
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

6.  Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

Authors:  Yan Ping Yu; Douglas Landsittel; Ling Jing; Joel Nelson; Baoguo Ren; Lijun Liu; Courtney McDonald; Ryan Thomas; Rajiv Dhir; Sydney Finkelstein; George Michalopoulos; Michael Becich; Jian-Hua Luo
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

7.  Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

Authors:  Neil H Segal; Paul Pavlidis; William S Noble; Cristina R Antonescu; Agnes Viale; Umadevi V Wesley; Klaus Busam; Humilidad Gallardo; Dianne DeSantis; Murray F Brennan; Carlos Cordon-Cardo; Jedd D Wolchok; Alan N Houghton
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

8.  A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer.

Authors:  Jeremy Chien; Julie Staub; Shou-Ih Hu; Michele R Erickson-Johnson; Fergus J Couch; David I Smith; Robert M Crowl; Scott H Kaufmann; Viji Shridhar
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

9.  Expression and localization of serine protease Htra1 in neuroblastoma: correlation with cellular differentiation grade.

Authors:  Velia D'Angelo; Giulia Pecoraro; Paolo Indolfi; Adriana Iannotta; Vittoria Donofrio; Maria Elena Errico; Cristiana Indolfi; Maria Ramaglia; Angela Lombardi; Martina Di Martino; Vincenzo Gigantino; Alfonso Baldi; Michele Caraglia; Antonio De Luca; Fiorina Casale
Journal:  J Neurooncol       Date:  2014-02-04       Impact factor: 4.130

10.  Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling.

Authors:  Sebastian Zimmer; Philip Kahl; Theresa M Buhl; Susanne Steiner; Eva Wardelmann; Sabine Merkelbach-Bruse; Reinhard Buettner; Lukas C Heukamp
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-11       Impact factor: 4.553
View more
  2 in total

1.  HtrA1 as a promising tissue marker in cancer: a meta-analysis.

Authors:  Emma Altobelli; Paolo Matteo Angeletti; Manrico Morroni; Valerio Filippo Profeta
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

2.  Novel therapeutic compounds for prostate adenocarcinoma treatment: An analysis using bioinformatic approaches and the CMap database.

Authors:  Kai Li; Jingyuan Fan; Xinyi Qin; Qingjun Wei
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.